A detailed history of Marshall Wace, LLP transactions in Illumina, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,239,763 shares of ILMN stock, worth $168 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,239,763
Previous 743,703 66.7%
Holding current value
$168 Million
Previous $77.6 Million 108.26%
% of portfolio
0.21%
Previous 0.11%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$105.28 - $135.9 $52.2 Million - $67.4 Million
496,060 Added 66.7%
1,239,763 $162 Million
Q2 2024

Aug 14, 2024

BUY
$101.05 - $133.57 $75.2 Million - $99.3 Million
743,703 New
743,703 $77.6 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $13.7 Million - $21.1 Million
148,023 New
148,023 $20.6 Million
Q4 2022

Feb 14, 2023

SELL
$187.24 - $242.74 $1.67 Million - $2.17 Million
-8,923 Reduced 17.04%
43,439 $8.78 Million
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $107 Million - $138 Million
-606,373 Reduced 92.05%
52,362 $9.99 Million
Q2 2022

Aug 15, 2022

BUY
$181.58 - $368.0 $110 Million - $224 Million
607,634 Added 1189.08%
658,735 $121 Million
Q1 2022

May 16, 2022

SELL
$303.87 - $423.8 $40.3 Million - $56.2 Million
-132,548 Reduced 72.17%
51,101 $17.9 Million
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $16 Million - $19.5 Million
46,147 Added 33.56%
183,649 $69.9 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $43.2 Million - $55.9 Million
106,583 Added 344.72%
137,502 $55.8 Million
Q2 2021

Aug 13, 2021

SELL
$372.84 - $481.5 $3.5 Million - $4.52 Million
-9,393 Reduced 23.3%
30,919 $14.6 Million
Q1 2021

May 17, 2021

BUY
$361.28 - $504.76 $14.6 Million - $20.3 Million
40,312 New
40,312 $15.5 Million
Q4 2020

Feb 16, 2021

SELL
$292.7 - $370.96 $30.8 Million - $39.1 Million
-105,360 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$268.51 - $400.74 $28.3 Million - $42.2 Million
105,360 New
105,360 $32.6 Million
Q1 2020

May 15, 2020

SELL
$209.2 - $335.53 $3.31 Million - $5.31 Million
-15,834 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$288.29 - $335.49 $394,380 - $458,950
-1,368 Reduced 7.95%
15,834 $5.25 Million
Q3 2019

Nov 14, 2019

SELL
$266.84 - $378.23 $767,965 - $1.09 Million
-2,878 Reduced 14.33%
17,202 $5.23 Million
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $5.54 Million - $6.79 Million
18,445 Added 1128.13%
20,080 $7.39 Million
Q1 2019

May 14, 2019

SELL
$272.57 - $321.18 $4.17 Million - $4.92 Million
-15,314 Reduced 90.35%
1,635 $508,000
Q4 2018

Feb 14, 2019

BUY
$272.46 - $366.54 $1.27 Million - $1.7 Million
4,651 Added 37.82%
16,949 $5.08 Million
Q3 2018

Nov 14, 2018

SELL
$279.04 - $367.06 $1.52 Million - $2 Million
-5,440 Reduced 30.67%
12,298 $4.51 Million
Q2 2018

Aug 14, 2018

BUY
$228.17 - $292.07 $2.53 Million - $3.24 Million
11,080 Added 166.42%
17,738 $4.95 Million
Q1 2018

May 15, 2018

BUY
$209.54 - $253.91 $1.4 Million - $1.69 Million
6,658 New
6,658 $1.57 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.3B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.